1. About molecular profile of lung cancer in Tunisian patients
    Faouzi Mezni et al, 2018, Journal of Immunoassay and Immunochemistry CrossRef
  2. Multi-disciplinary approach for the management of non-metastatic non-small cell lung cancer in the Middle East and Africa: Expert panel recommendations
    Erdem Göker et al, 2021, Lung Cancer CrossRef
  3. EGFR mutation status in a series of Turkish non-small cell lung cancer patients
    Gizem Calibasi-Kocal et al, 2020, Biomedical Reports CrossRef
  4. Advanced Non-small Cell Lung Cancer: EGFR Mutation Analysis Using Pyrosequencing and the Fully Automated qPCR-Based IdyllaTM System
    Youssra Boustany et al, 2023, Cancer Control CrossRef
  5. Prevalence and Patterns of EGFR Mutations in Non-small Cell Lung Cancer in the Middle East and North Africa
    Youssra Boustany et al, 2022, Cancer Control CrossRef
  6. Erlotinib in Patients with Advanced Non-small Cell Lung Cancer in Middle Eastern Population
    Abdul Rahman Jazieh et al, 2018, Journal of Immunotherapy and Precision Oncology CrossRef
  7. Frequency of Epidermal Growth Factor Receptor and T790M Mutations Among Patients With Non-Small Cell Lung Carcinoma: A Hospital-Based Study in the King Khalid University Hospital (KKUH) Since 2009-2017
    Sara H AlQahtani et al, 2021, Cureus CrossRef
  8. The Study of Druggable Targets in Nonsquamous Non-Small-Cell Lung Cancer in the Middle East and North Africa
    Abdul Rahman Jazieh et al, 2019, Journal of Immunotherapy and Precision Oncology CrossRef
  9. Evaluation of Two EGFR Mutation Tests on Tumor and Plasma from Patients with Non-Small Cell Lung Cancer
    Jeong-Oh Kim et al, 2020, Cancers CrossRef
  10. Lung Cancer in the Middle East and North Africa Region
    Abdulrahman R. Jazieh et al, 2019, Journal of Thoracic Oncology CrossRef
  11. Early Diagnosis of Lung Cancer in the United Arab Emirates: Challenges and Strategic Recommendations
    Humaid O. Al-Shamsi et al, 2021, Clinics and Practice CrossRef
  12. EGFR mutation frequency in Middle East and African non-small cell lung cancer patients: a systematic review and meta-analysis
    Zineb Benbrahim et al, 2018, BMC Cancer CrossRef
  13. Prevalence of programmed death ligand-1 in patients diagnosed with non-small cell lung cancer in Lebanon
    Ghina Fakhri et al, 2021, SAGE Open Medicine CrossRef
  14. Expert-Based Strategies to Improve Access to Cancer Therapeutics at the Hospital Level
    Abdul Rahman Jazieh et al, 2018, Global Journal on Quality and Safety in Healthcare CrossRef
  15. Targeted methods for molecular characterization of EGFR mutational profile in lung cancer Moroccan cohort
    Houda Kaanane et al, 2019, Gene CrossRef